Trelagliptin, TEGLIDX, Trelagliptin 100mg

Manufacturer: Laos Daxiong Pharmaceutical

Introduction: Trelagliptin was approved for marketing in Japan on March 26, 2015. It is an ultra-long-acting dipeptidyl peptidase IV (DPP-4) inhibitor that can effectively control blood sugar by taking only one tablet orally per week.

【Drug name】

Name: Trelagliptin Tablets

Product name:TEGLIDX

Chinese name: Trelagliptin tablets

【Specification】

100 mg

【Indications】

• TEGLIDX is a dipeptidyl peptidase 4 inhibitor used to manage type 2 diabetes.

【Recommended dosage】

• Take TEGLIDX exactly as your healthcare provider tells you to.

• Generally, adults take 100 mg of trelagliptin by mouth once a week. The score lines are not for dose adjustment. Do not break or crush the tablets.

【side effect】

• Hypersensitivity to trelagliptin or any of its ingredients; Patients with severe renal impairment or end-stage renal failure requiring dialysis. Hypoglycemia: Concomitant use of trelagliptin and sulfonylureas or insulin preparations may increase the risk of hypoglycemia.

• Allergies (rash, itching), atrial fibrillation, liver (elevated ALT, AST, – GTP), positive blood in urine, nasopharyngitis, elevated lipase, elevated amylase.

【Storage】

Storage temperature below 30°C

Keep TEGLIDX and all medicines out of the reach of children.